These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 4581672)

  • 41. [Current aspects of sterilization of carriers of Shigella].
    Procopan V; Struşievici B; Gavrilă I; Suciu O; Ardeleanu R
    Microbiol Parazitol Epidemiol (Bucur); 1969; 14(1):57-64. PubMed ID: 4888809
    [No Abstract]   [Full Text] [Related]  

  • 42. Results of dysentery vaccinations by live vaccine Vadizen (Sh. flexneri 2a T32-Istrati) in children collectivities in GL.
    Brebenel G; Barabas E; Delcea D; Meitert T; Pencu E; Ciudin L
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):299-304. PubMed ID: 6400303
    [No Abstract]   [Full Text] [Related]  

  • 43. Shigellosis in custodial institutions. II. Clinical, immunologic and bacteriologic response of institutionalized children to oral attenuated shigella vaccines.
    Levine MM; Dupont HL; Gangarosa EJ; Hornick RB; Snyder MJ; Libonati JP; Glaser K; Formal SB
    Am J Epidemiol; 1972 Jul; 96(1):40-9. PubMed ID: 4557072
    [No Abstract]   [Full Text] [Related]  

  • 44. Self-experiments with ingestion of various bacteria.
    Rédey B
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):45-62. PubMed ID: 4216252
    [No Abstract]   [Full Text] [Related]  

  • 45. Live dysentery vaccine "Vadizen" (T32-Istrati) immunogenicity against Shigella-like challenge in animals.
    Ciudin L; Meitert T; Pencu E; Gheorghe G; Tonciu M; Mihai I; Manase R
    Arch Roum Pathol Exp Microbiol; 1986; 45(3-4):247-56. PubMed ID: 3300598
    [No Abstract]   [Full Text] [Related]  

  • 46. [Use of antibacterial drugs in Shigella sonnei infections in childhood].
    Pöhlandt K; Greiner C; Handrick W
    Kinderarztl Prax; 1988 Nov; 56(11):547-50. PubMed ID: 3062230
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of intercurrent pathology on the immune response of the child's body in dysentery].
    Kuznietsov SV
    Pediatr Akus Ginekol; 1979; (6):7-8. PubMed ID: 392428
    [No Abstract]   [Full Text] [Related]  

  • 48. [Antidysenteric vaccination. XIV. Immunizing action on the guinea pig conjunctiva of various toxic extracts of pathogenic Shigella flexneri 2a TI, as compared with that of live cultures of two non-pathogenic strains of Shigella flexneri 2a].
    Istrati M; Istrati G
    Arch Roum Pathol Exp Microbiol; 1966 Mar; 25(1):55-64. PubMed ID: 5973711
    [No Abstract]   [Full Text] [Related]  

  • 49. [Importance of cellular and humoral immunity factors in dysentery in children].
    Tartakovskaia RA
    Vopr Okhr Materin Det; 1976 Nov; 21(11):43-5. PubMed ID: 795153
    [No Abstract]   [Full Text] [Related]  

  • 50. Adoptive transfer of immunity to dysentery bacilli with immune T lymphocytes from mice orally immunized with Shigella sonnei bacilli.
    Kowalewska D; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):593-601. PubMed ID: 7006564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Study on the effectiveness of a Sh. sonnei oral vaccine using the direct plaque technic].
    Thilo W; Seeger E; Schlosshardt J; Kriehn I; Poeplau A
    Z Gesamte Hyg; 1972 Oct; 18(10):756-8. PubMed ID: 4581673
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical trials of Shigella vaccines in Israel.
    Cohen D; Ashkenazi S; Green M; Gdalevich M; Yavzori M; Orr N; Robin G; Slepon R; Lerman Y; Block C; Ashkenazi I; Taylor D; Hale L; Sadoff J; Schneerson R; Robbins J; Wiener M; Shemer J
    Adv Exp Med Biol; 1996; 397():159-67. PubMed ID: 8718595
    [No Abstract]   [Full Text] [Related]  

  • 53. [Shigellosis abroad].
    Okolov IN; Brodianskiĭ IuM
    Tr Inst Im Pastera; 1983; 61():123-32. PubMed ID: 6379992
    [No Abstract]   [Full Text] [Related]  

  • 54. Studies on vaccination against bacillary dysentery. 4. Oral immunization with live monotypic and combined vaccines.
    Mel DM; Arsić BL; Nikolić BD; Radovanić ML
    Bull World Health Organ; 1968; 39(3):375-80. PubMed ID: 5303905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery.
    Phalipon A; Sansonetti P
    Biologicals; 1995 Jun; 23(2):125-34. PubMed ID: 7546655
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain.
    Ranallo RT; Thakkar S; Chen Q; Venkatesan MM
    Vaccine; 2007 Mar; 25(12):2269-78. PubMed ID: 17229494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prevention of dysentery infections in human collectivities by means of polyvalent bacteriophages S. flexneri and S. sonnei].
    Kostrzewski J; Mulczyk M; Slopek S
    Przegl Epidemiol; 1974; 28(4):483-507. PubMed ID: 4614332
    [No Abstract]   [Full Text] [Related]  

  • 58. [Increased effectiveness of antibiotic therapy with adaptogens in dysentery and Proteus infection in children].
    Vereshchagin IA; Geskina OD; Bukhteeva ER
    Antibiotiki; 1982 Jan; 27(1):65-9. PubMed ID: 7036851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunogenic value of live, inactivated and cell-free dysentery vaccines.
    Meitert T; Sulea IT; Gogulescu L; Baron E; Tempea C; Istrati G
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):103-7. PubMed ID: 4613127
    [No Abstract]   [Full Text] [Related]  

  • 60. Investigations concerning the immunoprophylactic effect of the antidysentery vaccination by live vaccine Vadizen (Sh. flexneri T32-Istrati) in children.
    Dragomir I; Iancu V; Călţun M; Raicu M; Meitert T; Pencu E; Ciudin L
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):323-9. PubMed ID: 6400306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.